Liposome encapsulated prednisolone(Enceladus Pharmaceuticals)

N/A

Report date: 2021/12/18 11:10:01

Base Information

Drug NameLiposome encapsulated prednisolone(Enceladus Pharmaceuticals)
Drug Alias NameNanocortPEG-liposomal prednisolone sodium phosphateLiposomal prednisoloneGLPG-0303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsGraves Ophthalmopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnceladus Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesThe Rotterdam Eye Hospital
Inactive CompaniesN/A
Active IndicationsGraves Ophthalmopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A